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Background: Pulmonary rehabilitation (PR) is an effective, evidenced-based treatment. Despite its proven effect, it is still underused.
The aim of this study was to present the number of patients with chronic obstructive pulmonary disease (COPD) who underwent PR,
general mortality percentages, the rate of patients prescribed PR by pulmonologists, and the distribution of institutions where PR was
performed between 2008 and 2016 in Turkey.
Materials and methods: The documents were obtained from Turkish Institution of Social Insurance. Ages, sexes, and numbers of
patients with COPD who underwent PR between 2008 and 2016 were recorded. The number of patients with COPD who had been
prescribed PR by physicians and the type of hospitals in which these patients underwent PR were identified. The general annual and
the general total mortality rates between 2008 and 2016 among patients with COPD who underwent PR in 2008 were also determined.
Results: The mean age ranges of patients with COPD who underwent PR were 67.4 ± 12.3 to 72.0 ± 13.2 years, and 62.2% (n =
60,852) of patients were male. The number of patients increased progressively from 3,214 to 18,664. The rate of patients prescribed PR
programs between 2008 and 2016 was between 0.32% and 0.59% among all registered patients with COPD. Between 52.0% and 94.8%
(5,488/10,549 and 16,792/17,707 patients, respectively) of the programs were prescribed by a pulmonologist, and 62.9% (n = 62,613)
of patients received PR in secondary public hospitals. The general annual mortality rates were between 6.2% and 11.1% (115/1,855 and
358/3,214 patients) in patients who underwent PR in 2008, and the general total mortality rate was 52.8% (1,696/3,214 patients) over
the 9-year period in the same patient group.
Conclusion: PR was still an underutilized approach in Turkey between 2008 and 2016. The awareness of PR should be increased in our
country. In order to achieve this, we think that PR should be within the scope of health policies.
Keywords: Pulmonary rehabilitation, chronic obstructive pulmonary disease, pulmonologist

1. Introduction
Chronic obstructive pulmonary disease (COPD) is
defined as “a common, preventable, and treatable disease
characterized by persistent respiratory symptoms and
airflow limitation that are due to airway or alveolar
abnormalities (or both), usually caused by significant
exposure to noxious particles or gases” [1]. It is
characterized by decreased exercise capacity, dyspnea,
worsened quality of life, and exacerbations, which result in
deterioration of these symptoms. As result of these factors,
both the progression and economic burden of the disease
becomes a serious problem. It has been shown to cause 2.9

million deaths per year worldwide, and is the third leading
cause of global death [2].
Pulmonary rehabilitation (PR) is an effective,
evidenced-based treatment modality in all symptomatic
patients with chronic respiratory disease whose exercise
capacity is reduced and quality of life is deteriorated,
regardless of disease severity [1]. It has been demonstrated
that PR is the most effective therapeutic approach for
improving dyspnea, health status, and exercise tolerance [3].
Besides exercise capacity and quality of life, the evidencebased benefits are important for improving recovery time
after hospitalization and reducing the perceived intensity

* Correspondence: tabiptarkan@hotmail.com

This work is licensed under a Creative Commons Attribution 4.0 International License.

141

ÖZDEMİR et al. / Turk J Med Sci
of breathlessness, number of hospitalizations, and days in
hospital. Additionally, it reduces hospitalizations among
patients who have had recent exacerbations [1]. When
considering these outcomes, it seems to be one of the most
cost-effective therapeutic strategies.
In Turkey, there are a limited number of pulmonary
rehabilitation units although the number of patients with
chronic respiratory problems is a growing burden. The
prevalence of COPD in the population aged over 40 years
was reported to range from 9.1% to 19.1% in Turkey [4–7]; a
national disease burden report revealed that COPD was
the third leading cause of mortality and the eighth leading
cause of disability [8]. There are several international
studies that show the rates of mortality in patients with
COPD receiving PR, but there is a lack of data on mortality
rates in those patients after PR programs in Turkey. There
is only limited inconclusive evidence to show that PR has
a significant beneficial effect on survival [9]. The aim of
this study was to present the number of patients with
COPD who underwent PR, general mortality percentages,
the rate of patients prescribed PR by pulmonologists, and
the distribution of institutions where PR was performed
between 2008 and 2016 in Turkey.
2. Materials and methods
2.1. Methods and data collection
This was a retrospective, observational, epidemiological,
and descriptive study. The data of our study were obtained
from the Turkish Institution of Social Insurance. Calculated
data were obtained because of the Turkish Institution of
Social Insurance’s security policy. The Turkish Institution
of Social Insurance covers almost the entire population
of Turkey (98.6%). The numbers of patients who were
diagnosed with COPD and followed between 2008 and
2016 were scanned from the Oracle database using the
TOAD data model program (version 9.6.0.27, Quest
Software, USA). The total number of patients with COPD
was recorded according to years. The age, sex, and number
of patients with COPD who underwent PR between 2008
and 2016 were recorded. The study was approved by the
local ethics committee.
2.2. Patients’ characteristics
The patients were diagnosed by a specialist. Patients aged
18 years and over were scanned, and the patients aged
over 40 years were selected. The number of patients with
COPD who underwent PR applications in different types
of hospitals was identified. The general annual and general
total mortality rates between 2008 and 2016 among
patients with COPD who underwent PR in 2008 were also
determined.
2.3. Definitions
General mortality was defined as death of unknown
causes. Annual mortality was calculated by the proportion
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of patients who died within one year to the number of
patients surviving at the beginning of the year (only
calculated among the patients who underwent PR in
2008). Total mortality was defined as the proportion of the
number of patients who died up to that year to the number
of survivors in the beginning of 2008 (only calculated
among the patients who underwent PR in 2008).
2.4. Statistical analysis
SAS software (SAS Institute, Inc., Cary, NC, USA) was used
for descriptive statistical analyses. Categorical variables
were expressed as numbers and percentages (%).
3. Results
The number of patients diagnosed with COPD and followed
in 2008 was 720,903, which increased to 3,434,262 in 2016.
From 2008 to 2015, the number of patients with COPD
who underwent PR increased progressively, from 3,214
to 18,664. In 2016, it was 17,707. The rate of patients who
underwent PR was between 0.32% and 0.59% between
2008 and 2016. The lowest rate was 0.32% (n = 4,043
and 6,307 in 2009 and 2011), while the highest rate was
0.59% (n = 17,566 in 2014) (Table 1; Figure 1). Between
52.0% and 94.8% (5,488/10,549 and 16,792/17,707
patients, respectively) of the programs were prescribed
by a pulmonologist between 2008 and 2016. The lowest
rate was 52.0% (n = 5,488 in 2012), while the highest rate
was 94.8% (n = 16,792 in 2016). Additionally, it appears
that the rate rose progressively from 2012 to 2016 (Table
1; Figure 2). The number of male patients (n = 60,852,
62.1%) was higher than that of female patients (n = 37,018,
37.8%). The mean age ranges were 67.4 ± 12.3 to 72.0 ±
13.2 years (Table 1). The general annual mortality rates
were between 6.2% and 11.1% (115/1,855 and 358/3,214
patients, respectively) in patients who underwent PR in
2008, and the general total mortality rate was found as
52.8% (1,696/3,214 patients) from 2008 to 2016 (Table 2).
When the distribution of institutions where PR
was performed was evaluated, the highest rates were in
secondary public hospitals (n = 62,613, 62.9%), followed by
tertiary public (n = 30,985, 31.1%), university (n = 4,838,
4.8%), private (n = 967, 0.9%), and foundation hospitals
(n = 111, 0.1%), respectively. Although from 20011 to
2016 the number of patients with COPD who underwent
PR applications in tertiary public hospital increased
progressively, the rates were variable in university,
secondary public, private, and foundation hospitals from
2008 to 2016. Furthermore, the number of patients who
presented to private hospitals from 2008 to 2016 decreased
(Table 3; Figure 3).
4. Discussion
This is the first study to report the rates of patients with
COPD who underwent PR in Turkey between 2008 and
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Table 1. Demographic features and ratios of patients with chronic obstructive pulmonary disease (COPD) who underwent pulmonary
rehabilitation (PR) and the rate of PR prescribed by pulmonologists.
Years

Total registered
patients with COPD n

Patients with COPD
who underwent PR n (%)

Sex Male /
Female n (%)

Age (years)
Mean

Patients with COPD who prescribed
PR by a pulmonologist n (%)

2008

720,903

3214 (0.44)

2,008 (62) / 1,206 (38)

72.0 ± 13.2

1,872

(58.2)

2009

1,228,182

4043 (0.32)

2,490 (62) / 1,553 (38)

70.4 ± 13.6

2,404

(59.4)

2010

1,638,303

6847 (0.41)

4,086 (60) / 2,761 (40)

69.6 ± 13.6

4,630

(67.6)

2011

1,962,833

6307 (0.32)

3,981 (63) / 2,326 (37)

69.6 ± 13.7

3,308

(52.4)

2012

2,344,777

10,549 (0.44)

6,322 (60) / 4,227 (40)

68.7 ± 14.1

5,488

(52.0)

2013

2,662,513

12,973 (0.48)

8,055 (62) / 4,918 (38)

68.7 ± 13.2

8,263

(63.8)

2014

2,946,215

17,566 (0.59)

10,801 (61) / 6,765 (39)

68.7 ± 12.9

15,598 (88.7)

2015

3,211,459

18,664 (0.58)

11,651 (62) / 7,013 (38)

67.8 ± 12.9

17,465 (92.5)

2016

3,434,262

17,707 (0.51)

11,458 (65) / 6,249 (35)

67.4 ± 12.3

16,792 (94.8)

Figure 1. The ratio of patients with chronic obstructive pulmonary disease (COPD)
who underwent pulmonary rehabilitation (PR) among all registered patients with
COPD.

Figure 2. The ratio of patients with chronic obstructive pulmonary disease (COPD)
who underwent pulmonary rehabilitation (PR) prescribed by a pulmonologist.
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Table 2. The general mortality rate of patients with chronic
obstructive pulmonary disease (COPD) who underwent
pulmonary rehabilitation (PR) in 2008.
Patients

Annual mortality

Total mortality

n

n (%)

n (%)

2008

3,214

358 (11.1)

358 (11.1)

2009

2,856

292 (10.2)

650 (20.2)

2010

2,564

217 (8.5)

867 (26.9)

2011

2,347

197 (8.4)

1,064 (33.1)

2012

2,150

148 (6.9)

1,212 (37.7)

2013

2,002

147 (7.3)

1,359 (42.3)

2014

1,855

115 (6.2)

1,474 (45.9)

2015

1,740

111 (6.4)

1,585 (49.3)

2016

1,629

111 (6.8)

1,696 (52.8)

2016 New Zealand audit, McNaughton et al. reported that
only 2% of the expected COPD population was referred
for PR, whereas in England and Wales, 68,000 (15.2%)
of 446,000 eligible patients were referred [20]. A study
investigated the frequency of referral for and attendance
at PR among patients with COPD admitted to a tertiary
Australian hospital in 2011; 57% of patients had been
referred to PR at some stage of their disease, 18% had
undergone PR at some point, and only 8% had received
PR within the previous 2 years [21]. This referral rate was
similar to that reported 10 years previously in a different
Australian hospital, in a review of 49 patients with COPD
[22]. Similarly, two studies from the United Kingdom
reported referral to rehabilitation at the time of admission
as 3% (42/1,400 patients) [23] and 18% (9/50 patients) [24].
It was emphasized that there was little change in referrals to
PR in the last decade, in spite of the increased availability of
programs and more widespread knowledge of effectiveness
of PR. Keating et al. reported that uptake of PR had
traditionally been poor, with up to half of the patients who
were offered a course not attending PR sessions [25]. In our
study, the rate of patients who underwent PR was about
0.32%–0.59% per year between 2008 and 2016. The lowest
rate was 0.32% in 2009 and 2011, and the highest rate was
0.59% in 2014. Our rates were lower than in other studies.
This could be due to the fact that our study consisted of a
higher number of patients with COPD. We suggest that it
was likely due to the low number of PR center and units
and low awareness of PR among both health professionals
and patients. In our study, there were more male patients
than female in each year. The mean age ranges were 67.4 ±
12.3 to 72.0 ± 13.2 years. Similar to our study, in another
study, the mean age of patients with COPD was 72 ± 11
years, and the majority was male, consistent with COPD
features in the PR group [21].
In addition to the several benefits of PR described
previously, PR has been associated with improved survival
in patients with COPD after an acute exacerbation [26];
however, there are inconsistent data about improving

2016, and to establish the number of patients with COPD
who were prescribed PR by pulmonologists in the same
period. This study showed that the rate of patients who
underwent PR was about 0.32%–0.59%, there was a male
predominance, and the mean age ranges were 67.4 ± 12.3 to
72.0 ± 13.2 years. The general annual mortality rates were
6.2%–11.1% in patients who underwent PR in 2008, and
the general total mortality rate was 52.8% over the 9-year
period in the same patient group. The number of patients
with COPD who underwent PR was found to increase
progressively. It was shown that PR was prescribed to more
than half of the patients by pulmonologists. Additionally,
PR was mostly performed in public hospitals.
Despite the proven benefits of PR, referral to PR
programs still remains poor worldwide, regardless of
the accessibility of PR [10–12]. Various rates have been
reported; it is estimated that <5% of eligible patients
received PR annually [13,14], but in some reports it has
been found higher with rates of 3%–16% [15–19]. In their

Table 3. Distribution of patients with chronic obstructive pulmonary disease (COPD) who underwent pulmonary rehabilitation (PR)
according to hospital type.
2008
n

2009
n

2010
n

2011
n

2012
n

2013
n

2014
n

2015
n

2016
n

Total
n (%)

Secondary public

1,481

2,318

4,146

3,912

7,957

9,526

12,357

11,494

9,422

62,613 (62.9)

Tertiary public

1,029

1,158

2,343

2,039

2,328

3,263

4,662

6,633

7,530

30,985 (31.1)

University

567

489

226

209

267

253

873

844

1,110

4,838 (4.8)

Private (secondary)

201

149

213

204

72

67

19

21

21

967 (0.9)

Foundation

0

4

3

4

29

18

13

10

30

111 (0.1)

Total number

3,278

4,118

6,931

6,368

10,653

13,127

17,924

19,002

18,113

99,514

144

ÖZDEMİR et al. / Turk J Med Sci

Figure 3. Distribution of patients with chronic obstructive pulmonary disease (COPD)
who underwent pulmonary rehabilitation (PR) according to hospital type.

survival in stable patients with COPD due to nonsignificant
differences between mortality rates [27,28]. In a cohort
study, survival was investigated in 158 patients who
completed a PR program, 87% of whom had COPD, and
the survival rate was 80% at 3 years after rehabilitation
[29]. In other studies, survival rates were 91%–95% at 1
year [30,31] and 73% at 4 years after rehabilitation [30].
Another study demonstrated that the survival rate was 67%
at 6 years in the PR group [28]. In our study, the general
annual mortality rates were between 6.2% and 11.1% in
patients who underwent PR in 2008, and the general total
mortality rate was 52.8% over the 9-year period.
Several factors affect attendance and referral to PR
programs. Suboptimal healthcare professional awareness of
PR is currently a barrier to patient referral [32]. In a recent
study, it was shown that one of the most important reasons
for nonattendance or referral was a lack of knowledge of
the effectiveness of PR [4]. For the purpose of increasing
referrals of patients to PR, the awareness of PR among
healthcare professionals should be increased, along with
that of patients. Education and training programs are
recommended even for pulmonologists in recent guidelines
[33]. In a study conducted in Turkey, primary healthcare
providers such as family practitioners and homecare staff
were found to have inadequate information about COPD
and PR [34]. In a Turkish survey study, it was reported that
the levels of knowledge of chest physicians about PR was
substantially in the range of low to moderate in a small
city of Turkey [35]. In our study, the rates of patients with
COPD whose programs were prescribed by pulmonologists
were 50% and over from 2008 to 2016. It seems that the
awareness of pulmonologists increased progressively from
2012 to 2016. In 2016, the rate was 94.8%.
Another possible factor that influences attendance and
referral to PR programs is health systems and policies. In

our study, when the distribution of institutions where PR
was performed was evaluated, the highest rates per year were
in secondary public hospitals. Secondary public hospitals
were followed by tertiary public, private, and university and
foundation hospitals, respectively. Although the number
of patients with COPD who underwent PR applications
in tertiary public hospitals from 2011 to 2016 increased
progressively, the rates were variable in university, secondary
public, private, and foundation hospitals from 2008 to
2016. Furthermore, the number of patients who presented
to private hospitals from 2008 to 2016 decreased. Since a
patient may present to more than one health institution, the
calculated number of patients with COPD who underwent
PR would be higher in terms of institutional distribution.
The limitation of this study is the lack of information
about the duration and content of PR programs and the
number of PR centers/units. Due to the lack of a definition
of PR centers and units in Turkey, these data could not be
obtained from the Turkish Institution of Social Insurance.
The data for every patient could not be obtained because of
the information security policy of the Turkish Institution of
Social Insurance. The records in the Turkish Institution of
Social Insurance began in 2017. Therefore, the number of
patients diagnosed with COPD in 2008 may be lower than
expected.
In conclusion, this study showed that although the
awareness of PR, especially in pulmonologists, and the
number of patients with COPD who underwent PR tended
to increase in public hospitals, PR was still an underutilized
approach in Turkey between 2008 and 2016. The awareness
of PR should be increased in our country. In order to
achieve this, we think that PR should be within the scope
of health policies. Further studies are needed to identify
referral problems and reasons for the lack of awareness of
the effectiveness of PR.
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